Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06410989 · ClinicalTrials.gov registry record
Evaluation of Sensorimotor Ankle Impairments in Chronic Stroke
A clinical trial, sponsored by Shirley Ryan AbilityLab.
- Not yet
- Registry status
- 80
- Enrollment target
NCT06410989: Clinical Trial study, sponsored by Shirley Ryan AbilityLab.
NCT06410989 is a clinical trial that has not yet begun recruiting, run by Shirley Ryan AbilityLab. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06410989 has not yet begun recruiting, sponsored by Shirley Ryan AbilityLab.
- NOT YET RECRUITING
- Registry status
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to capture sensorimotor ankle function in a chronic stroke population through validation of novel, experimental metrics and their comparison with established, clinical measures of function. For this purpose, the researchers will evaluate various single-joint, impairment-level measures such as visuomotor tracking performance and proprioception as well as functional-level measures including spatiotemporal gait (e.g., gait speed and stride length/time) and standardized clinical scales. This study will be carried out in chronic stroke patients as well as age-matched healthy controls. Results will help the researchers identify more quantitative metrics that can be used to monitor and rehabilitate sensorimotor function following stroke.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-07-15 |
| Est. Completion | 2027-08-31 |
What is known before NCT06410989 opens enrollment
NCT06410989 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT06410989 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06410989 about?
NCT06410989 is a clinical study titled "Evaluation of Sensorimotor Ankle Impairments in Chronic Stroke". The purpose of this study is to capture sensorimotor ankle function in a chronic stroke population through validation of novel, experimental metrics and their comparison with established, clinical measures of function. For this purpose, the researchers will evaluate various single-joint, impairment-...
What is the current status of trial NCT06410989?
This trial is currently not yet recruiting. The enrollment target is 80 participants. The study started on 2025-07-15. Estimated completion is 2027-08-31.
Who is sponsoring clinical trial NCT06410989?
This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI